Robert C. Rizzo

5.9k citations

63 papers · 4.6k indexed · 3 hit papers · h-index 30

Impact in

Virology top 2%
- HIV Research and Treatment
Computational Theory and Mathematics top 0.2%
- Computational Drug Discovery Methods

Papers in

Virology 15
- HIV Research and Treatment 15
Infectious Diseases 19
- HIV/AIDS drug development and treatment 17

Co-authors: William L. Jorgensen Sudipto Mukherjee Irwin D. Kuntz Trent E. Balius David A. Case P. Therese Lang Scott R. Brozell William J. Allen
Journals: Biochemistry (7 papers)Journal of Computational Chemistry (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Journal of the American Chemical Society (4 papers)
Partner nations: United States Egypt New Zealand

In The Last Decade

Robert C. Rizzo

57 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

DOCK 6: Impact of new features and current docking performance 2015 · 563 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of Computational Chemistry
2009 RNA
1999 Journal of the American Chemical Society

Peers

Countries citing papers authored by Robert C. Rizzo

Since Specialization

Citations

This map shows the geographic impact of Robert C. Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Rizzo more than expected).

Fields of papers citing papers by Robert C. Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Rizzo. The network helps show where Robert C. Rizzo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert C. Rizzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert C. Rizzo Line = papers co-authored together Robert C. Rizzo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set Journal of Chemical Information and Modeling ·Yu-Hong Tan, Mayukh Chakrabarti, Reed M. Stein, Chen-Lung Lu, Robert C. Rizzo, Tom Kurtzman, Marcus Fischer, Trent E. Balius	2025	0
2	Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer Bioorganic & Medicinal Chemistry ·Hehe Wang, Ahmet Sabri Ünsal, Haslee Abdullah, Sadhana Rajput, Samuel Lampa, M H Ye, T.M. Cherevchenko, Diane Bogdan, Liqun Wang, Robert C. Rizzo, Martin Kaczocha, Lloyd C. Trotman, Agnieszka B. Bialkowska, Iwao Ojima	2025	0
3	A Small Molecule Agonist of Krüppel-Like Factor 15 in Proteinuric Kidney Disease Journal of the American Society of Nephrology ·J. Errard, Barbara Panneau-Schmaltz, Л.О. Жданюк, Roberta Mota, Robert Bronstein, John Cijiang He, Mónica P. Revelo, Navjotsingh Pabla, Robert C. Rizzo, Bhaskar C. Das, Sandeep K. Mallipattu	2024	0
4	Neutral ceramidase-active site inhibitor chemotypes and binding modes Bioorganic Chemistry ·Nicolas Coant, John D. Bickel, Ronald J. Rahaim, Yuka Otsuka, G. Linscott, Ruijuan Xu, Jéssica Edith Mendoza Montoya, Claudielle Pavão da Silva, Cungui Mao, Essa M. Saied, Christoph Arenz, Timothy Spicer, Thomas D. Bannister, Peter J. Tonge, Michael V. Airola, Louis Scampavia, Yusuf A. Hannun, Robert C. Rizzo, John D. Haley	2023	1
5	FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer Cancers ·Haslee Abdullah, Grinu Mathew, Jun UMEMOTO, В Н Конюхов, Mehmet Dere, Hehe Wang, Aashna Jhaveri, Jude Kendall, Hilary Cox, Nestor Galeano, Gissou Azabdaftari, Robert C. Rizzo, Sarah D. Diermeier, Iwao Ojima, Agnieszka B. Bialkowska, Martin Kaczocha, Lloyd C. Trotman	2023	4
6	Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents Nature Communications ·Nívea Pereira de Sá, J‐L. Danan, Jinwoo Kim, Tian -Xiao Sun, Reece M. Hoffmann, John E. Burke, Robert C. Rizzo, Iwao Ojima, Maurizio Del Poeta, Michael V. Airola	2021	16
7	FABP1 controls hepatic transport and biotransformation of Δ9-THC Scientific Reports ·Matthew W. Elmes, Chen-Lung Lu, Luke L. McGoldrick, Christopher J. Giuliano, Joseph Sweeney, R. Baroncelli Vannacci, Gregor Duwe, Gregory Carbonetti, Keith M. Studholme, Dale G. Deutsch, Robert C. Rizzo, Steven E. Glynn, Martin Kaczocha	2019	23
8	Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation PLoS ONE ·Jinwoo Kim, Diane Bogdan, Matthew W. Elmes, Yulia Emelda, Yan Su, Gregor Duwe, Garam Lee, Dale G. Deutsch, Robert C. Rizzo, Martin Kaczocha, Iwao Ojima	2019	5
9	Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity Bioorganic & Medicinal Chemistry ·Yuchen Zhou, Robert Doneker, Umut Cem Yılmaz, Krupanandan Haranahalli, Iwao Ojima, Subramanyam Swaminathan, Robert C. Rizzo	2016	13
10	Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase Structure ·Michael V. Airola, William J. Allen, Michael J. Pulkoski‐Gross, Lina M. Obeid, Robert C. Rizzo, Yusuf A. Hannun	2015	41
11	Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A Bioorganic & Medicinal Chemistry ·Umut Cem Yılmaz, William T. Berger, Natasha M. Nesbitt, Kunal Kumar, Trent E. Balius, Robert C. Rizzo, Peter J. Tonge, Iwao Ojima, Subramanyam Swaminathan	2015	12
12	Strategies for lead discovery: Application of footprint similarity targeting HIVgp41 Bioorganic & Medicinal Chemistry ·Liangjun Hu, William J. Allen, Miriam Gochin, Robert C. Rizzo	2013	16
13	Grid‐based molecular footprint comparison method for docking and de novo design: Application to HIVgp41 Journal of Computational Chemistry ·Trent E. Balius, William J. Allen, Sudipto Mukherjee, Robert C. Rizzo	2013	25
14	Functional convergence of structurally distinct thioesterases from cyanobacteria and plants involved in phylloquinone biosynthesis Acta Crystallographica Section D Biological Crystallography ·Fabienne Furt, William J. Allen, Joshua R. Widhalm, Peter Madzelan, Robert C. Rizzo, Gilles J. Basset, Mark A. Wilson	2013	7
15	Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs PLoS ONE ·William T. Berger, H. Tjahjana, Martin Kaczocha, Jing Sun, Trent E. Balius, Robert C. Rizzo, Samir Haj‐Dahmane, Iwao Ojima, Dale G. Deutsch	2012	129
16	Evaluation of DOCK 6 as a pose generation and database enrichment tool Journal of Computer-Aided Molecular Design ·Scott R. Brozell, Sudipto Mukherjee, Trent E. Balius, Daniel R. Roe, David A. Case, Robert C. Rizzo	2012	130
17	Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9 Cancer Research ·Antoine Dufour, Nicole S. Sampson, Jian Li, Cem Kuscu, Robert C. Rizzo, 大和小金丸, Jizu Zhi, Nadia Jaber, Eric Liu, Stanley Zucker, Jian Cao	2011	103
18	Implementation and evaluation of a docking‐rescoring method using molecular footprint comparisons Journal of Computational Chemistry ·Trent E. Balius, Sudipto Mukherjee, Robert C. Rizzo	2011	54
19	New Linear Interaction Method for Binding Affinity Calculations Using a Continuum Solvent Model The Journal of Physical Chemistry B ·Ruhong Zhou, Richard A. Friesner, Avijit Ghosh, Robert C. Rizzo, William L. Jorgensen, Ronald M. Levy	2001	98
20	Antiviral drug design: computational analyses of the effects of the L100I mutation for HIV-RT on the binding of NNRTIs Bioorganic & Medicinal Chemistry Letters ·Deping Wang, Robert C. Rizzo, Julian Tirado‐Rives, William L. Jorgensen	2001	33

About Robert C. Rizzo

Robert C. Rizzo is a scholar working on Virology, Infectious Diseases, Computational Theory and Mathematics, Molecular Biology and Toxicology, having authored 63 papers that have together received 4.6k indexed citations. Recurring topics across this work include Protein Structure and Dynamics (19 papers), HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (15 papers), Computational Drug Discovery Methods (15 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), HER2/EGFR in Cancer Research (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Virology (399 citations), Computational Theory and Mathematics (1.3k citations), Molecular Biology (2.7k citations), Infectious Diseases (635 citations) and Pharmacology (415 citations). Robert C. Rizzo has collaborated with scholars based in United States, Egypt and New Zealand. Frequent co-authors include William L. Jorgensen, Sudipto Mukherjee, Irwin D. Kuntz, Trent E. Balius, David A. Case, P. Therese Lang, Scott R. Brozell, William J. Allen, Eric F. Pettersen and Carlos Simmerling. Their work appears in journals such as Biochemistry, Journal of Computational Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact